CVE:NXG NexgenRx (NXG) Stock Price, News & Analysis C$0.29 -0.01 (-1.69%) As of 05/1/2025 11:59 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesBuy This Stock About NexgenRx Stock (CVE:NXG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NexgenRx alerts:Sign Up Key Stats Today's RangeC$0.27▼C$0.2950-Day RangeC$0.25▼C$0.3052-Week RangeC$0.22▼C$0.35Volume40,046 shsAverage Volume36,819 shsMarket CapitalizationC$20.57 millionP/E RatioN/ADividend Yield3.45%Price TargetN/AConsensus RatingN/A Company OverviewNexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.Read More… Receive NXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. Email Address NXG Stock News HeadlinesNexgenRx Announces Declaration of DivdendApril 17, 2025 | markets.businessinsider.comNexgenRx Declares Dividend, Reinforcing Shareholder ValueApril 17, 2025 | tipranks.comThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?May 3, 2025 | Timothy Sykes (Ad)NexgenRx Inc.: NexgenRx Announces Third Quarter Results and Declaration of DivdendNovember 26, 2024 | finanznachrichten.deCan NexgenRx Inc.'s (CVE:NXG) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?November 26, 2024 | uk.finance.yahoo.comNexgenRx Announces Third Quarter Results and Declaration of DivdendNovember 26, 2024 | finance.yahoo.comNexgenRX Inc.September 19, 2024 | wsj.comClosing Bell: Nexgenrx Inc up on Monday (NXG)July 20, 2024 | theglobeandmail.comSee More Headlines NXG Stock Analysis - Frequently Asked Questions How have NXG shares performed this year? NexgenRx's stock was trading at C$0.28 at the beginning of the year. Since then, NXG stock has increased by 5.5% and is now trading at C$0.29. View the best growth stocks for 2025 here. How do I buy shares of NexgenRx? Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of NexgenRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that NexgenRx investors own include WestJet Airlines (WJA), Vision Marine Technologies (VMAR), Hydro One (H) and Carvana (CVNA). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Healthcare Plans Sub-IndustryN/A Current SymbolCVE:NXG CIKN/A Webwww.nexgenrx.com Phone+1-416-6953393FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.06 million Net Margins-0.17% Pretax MarginN/A Return on Equity-0.31% Return on Assets0.42% Debt Debt-to-Equity Ratio6.16 Current Ratio1.08 Quick Ratio0.12 Sales & Book Value Annual SalesC$15.34 million Price / Sales1.34 Cash FlowC$0.03 per share Price / Cash Flow9.64 Book ValueC$0.09 per share Price / Book3.22Miscellaneous Outstanding Shares70,920,000Free FloatN/AMarket CapC$20.57 million OptionableNot Optionable Beta0.29 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (CVE:NXG) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.